Markus Joerger
Department of Pharmacy and Pharmacology
Slotervaart Hospital/The Netherlands Cancer Institute
Amsterdam
the Netherlands; Department of Clinical Pharmacology
Switzerland
Name/email consistency: high
- Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: A prospective clinical study. Joerger, M., Burgers, S.A., Baas, P., Smit, E.F., Haitjema, T.J., Bard, M.P., Doodeman, V.D., Smits, P.H., Vincent, A., Huitema, A.D., Beijnen, J.H., Schellens, J.H. Cancer (2012)
- Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine. Joerger, M., Burgers, J.A., Baas, P., Doodeman, V.D., Smits, P.H., Jansen, R.S., Vainchtein, L.D., Rosing, H., Huitema, A.D., Beijnen, J.H., Schellens, J.H. Cancer Chemother. Pharmacol. (2012)
- Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates. Joerger, M., Templeton, A., Köberle, D., Engler, H., Riesen, W.F., Thürlimann, B. Cancer Chemother. Pharmacol. (2011)
- The role of pemetrexed in advanced non small-cell lung cancer: special focus on pharmacology and mechanism of action. Joerger, M., Omlin, A., Cerny, T., Früh, M. Curr. Drug. Targets (2010)
- Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial. Joerger, M., Huitema, A.D., Krähenbühl, S., Schellens, J.H., Cerny, T., Reni, M., Zucca, E., Cavalli, F., Ferreri, A.J. Br. J. Cancer (2010)
- CT-diagnosed mesenteric alterations in patients with non-Hodgkin's lymphoma: a population-based study. Joerger, M., Nuessli, D.F., Henz, S., Zaunbauer, W., Cerny, T., Cogliatti, S.B., Gillessen, S. Onkologie (2008)
- Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic-pharmacodynamic study. Joerger, M., Huitema, A.D., Huizing, M.T., Willemse, P.H., de Graeff, A., Rosing, H., Schellens, J.H., Beijnen, J.H., Vermorken, J.B. Br. J. Clin. Pharmacol (2007)
- Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group. Joerger, M., Huitema, A.D., Richel, D.J., Dittrich, C., Pavlidis, N., Briasoulis, E., Vermorken, J.B., Strocchi, E., Martoni, A., Sorio, R., Sleeboom, H.P., Izquierdo, M.A., Jodrell, D.I., Calvert, H., Boddy, A.V., Hollema, H., Féty, R., Van der Vijgh, W.J., Hempel, G., Chatelut, E., Karlsson, M., Wilkins, J., Tranchand, B., Schrijvers, A.H., Twelves, C., Beijnen, J.H., Schellens, J.H. Clin. Cancer Res. (2007)
- Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG. Joerger, M., Huitema, A.D., Richel, D.J., Dittrich, C., Pavlidis, N., Briasoulis, E., Vermorken, J.B., Strocchi, E., Martoni, A., Sorio, R., Sleeboom, H.P., Izquierdo, M.A., Jodrell, D.I., Féty, R., de Bruijn, E., Hempel, G., Karlsson, M., Tranchand, B., Schrijvers, A.H., Twelves, C., Beijnen, J.H., Schellens, J.H. Clin. Pharmacokinet (2007)
